BUSINESS COMBINATION AGREEMENT by and among YishengBio Co., Ltd., Oceanview Bioscience Acquisition Co., Ltd., Hudson Biomedical Group Co., Ltd., and Summit Healthcare Acquisition Corp. dated as of September 29, 2022Business Combination Agreement • September 29th, 2022 • YishengBio Co., LTD • Blank checks • New York
This Business Combination Agreement, dated as of September 29, 2022 (this “Agreement”), is made and entered into by and among (i) YishengBio Co., Ltd., an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), (ii) Oceanview Bioscience Acquisition Co., Ltd., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub I”), (iii) Hudson Biomedical Group Co., Ltd., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub II”, collectively with Merger Sub I, the “Merger Subs” and each, a “Merger Sub”), and (iv) Summit Healthcare Acquisition Corp., an exempted company limited by shares incorporated under the laws of the Cayman Islands (“SPAC”).
